UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000029876
Receipt No. R000034118
Scientific Title Development of Safe Peri-operative Management for Surgical Patients using Body Composition Analyser
Date of disclosure of the study information 2017/11/09
Last modified on 2019/05/13 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Development of Safe Peri-operative Management for Surgical Patients using Body Composition Analyser
Acronym InBody and Preoperative Management
Scientific Title Development of Safe Peri-operative Management for Surgical Patients using Body Composition Analyser
Scientific Title:Acronym InBody and Preoperative Management
Region
Japan

Condition
Condition Cancer
Classification by specialty
Hematology and clinical oncology Surgery in general Hepato-biliary-pancreatic surgery
Chest surgery Breast surgery Operative medicine
Blood transfusion Intensive care medicine Rehabilitation medicine
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Surgical interventions and chemotherapy affect the body composition of patients, depending on the target organs, surgical techniques, stage of the disease and fluid/nutrition management. The change in the body composition is one of the important factors to influence the post operative recovery and complication rate. In this study, we plan to measure the body composition of patients in both inpatient and outpatient settings in Kawasaki Medical School General Medical Centre, using InBody 770&S1, which are highly sophisticated non-invasive body composition analysers involving bioelectrical impedance. Our aim is to investigate if the body composition analysis would become a safe and efficient assessment tool for peri-operative management of surgical patients.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Post operative complications based on Clavien-Dindo classification
Key secondary outcomes Other adverse event based on CTCAEv4.0, duration of stay in ICU, other clinical information from medical records

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <
Age-upper limit
20 years-old >=
Gender Male and Female
Key inclusion criteria All surgical patients who undergo operations and/or are receiving chemotherapy at Kawasaki Medical School General Medical Centre
Key exclusion criteria Anyone not include above
Target sample size 300

Research contact person
Last name of lead principal investigator
1st name Tomoki
Middle name
Last name Yamatuji
Organization Kawasaki Medical School
Division name Department of General Surgery
Zip code 700-8505
Address 2-6-1, Nakasange, Kita-Ward, Okayama-City, Okayama-Prefecture
TEL 0862252111
Email yama-t@med.kawasaki-m.ac.jp

Public contact
1st name of contact person
1st name Tomoki
Middle name
Last name Yamatuji
Organization Kawasaki Medical School
Division name Department of General Surgery
Zip code 700-8505
Address 2-6-1, Nakasange, Kita-Ward, Okayama-City, Okayama-Prefecture
TEL 0862252111
Homepage URL
Email yama-t@med.kawasaki-m.ac.jp

Sponsor
Institute Kawasaki Medical School
Department of General Surgery
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Kawasaki Medical School Hospital Ethics Committee
Address 577 Matsushima Kurashiki City Okayama Prefecture
Tel 086-464-1076
Email kmsrec@med.kawasaki-m.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 11 Month 09 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2017 Year 08 Month 02 Day
Date of IRB
2017 Year 08 Month 10 Day
Anticipated trial start date
2017 Year 08 Month 02 Day
Last follow-up date
2023 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Non applicable

Management information
Registered date
2017 Year 11 Month 08 Day
Last modified on
2019 Year 05 Month 13 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000034118